Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Roblox
RBLX
|
$557M |
| 2 |
JPMorgan Chase
JPM
|
$497M |
| 3 |
Amazon
AMZN
|
$492M |
| 4 |
AT&T
T
|
$448M |
| 5 |
Coinbase
COIN
|
$338M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$893M |
| 2 |
Advanced Micro Devices
AMD
|
$706M |
| 3 |
Qualcomm
QCOM
|
$580M |
| 4 |
Adobe
ADBE
|
$542M |
| 5 |
Johnson & Johnson
JNJ
|
$455M |
Sector Composition
| 1 | Healthcare | 19.45% |
| 2 | Technology | 17.76% |
| 3 | Consumer Staples | 10.28% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Financials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AT&T
T
$208B
| $461M | 0.57% |
18,733,486
+18,195,486
| +3,382% | +$448M |
|
27
GSK
GSK
$78.5B
| $451M | 0.56% |
10,225,421
+811,000
| +9% | +$35.8M |
|
28
Icon
ICLR
$13.8B
| $439M | 0.55% |
1,417,758
-136,800
| -9% | -$42.4M |
|
29
Berkshire Hathaway Class A
BRK.A
$1.09T
| $415M | 0.52% |
920
+519
| +129% | +$234M |
|
30
Vodafone
VOD
$28.3B
| $389M | 0.48% |
26,050,832
-2,526,900
| -9% | -$37.7M |
|
31
Exxon Mobil
XOM
$489B
| $386M | 0.48% |
6,313,354
+3,619,270
| +134% | +$221M |
|
32
Target
TGT
$42B
| $383M | 0.48% |
1,656,720
-1,429,239
| -46% | -$331M |
|
33
Chevron
CVX
$326B
| $382M | 0.48% |
3,253,895
+730,170
| +29% | +$85.7M |
|
34
Micron Technology
MU
$133B
| $379M | 0.47% |
4,066,036
+2,431,300
| +149% | +$226M |
|
35
Medtronic
MDT
$120B
| $370M | 0.46% |
3,574,541
+3,116,700
| +681% | +$322M |
|
36
Fortinet
FTNT
$58.9B
| $364M | 0.45% |
1,012,789
-47,100
| -4% | -$16.9M |
|
37
Vertex Pharmaceuticals
VRTX
$100B
| $357M | 0.44% |
1,626,868
-264,618
| -14% | -$58.1M |
|
38
National Grid
NGG
$67.5B
| $356M | 0.44% |
4,925,268
-240,009
| -5% | -$17.4M |
|
39
Herbalife
HLF
$1.01B
| $344M | 0.43% |
8,394,564
-354,000
| -4% | -$14.5M |
|
40
AstraZeneca
AZN
$249B
| $339M | 0.42% |
5,818,828
-1,065,548
| -15% | -$62.1M |
|
|
41
Coinbase
COIN
$78B
| $338M | 0.42% |
+1,338,300
| New | +$338M |
|
42
Incyte
INCY
$16.8B
| $337M | 0.42% |
4,590,733
+179,500
| +4% | +$13.2M |
|
43
F5
FFIV
$18B
| $333M | 0.41% |
1,361,062
-176,800
| -11% | -$43.3M |
|
44
Novartis
NVS
$245B
| $326M | 0.41% |
3,727,570
+420,333
| +13% | +$36.8M |
|
45
Texas Instruments
TXN
$182B
| $321M | 0.4% |
1,704,000
+1,333,800
| +360% | +$251M |
|
46
Bristol-Myers Squibb
BMY
$96.5B
| $314M | 0.39% |
5,040,786
-2,080,139
| -29% | -$130M |
|
47
Exelixis
EXEL
$10B
| $313M | 0.39% |
17,100,778
-446,723
| -3% | -$8.17M |
|
48
Verizon
VZ
$185B
| $304M | 0.38% |
5,848,271
+4,151,749
| +245% | +$216M |
|
49
Cboe Global Markets
CBOE
$24.7B
| $301M | 0.37% |
2,310,824
-143,600
| -6% | -$18.7M |
|
50
General Mills
GIS
$26.4B
| $290M | 0.36% |
4,300,188
+29,300
| +0.7% | +$1.97M |
|